Analyst Ratings for Neurogene (NGNE)
NGNE Rating Summary
NGNE Price Target Summary
- Highest: $166.00 (Canaccord)
- Lowest: $46.00 (Stifel)
- Average: $74.22
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$74.22 (+219.2%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 89%
Avg. $ Target:
$74.22 (+219.2%)
* Over Last 12-Mos
Rating Score: 9.1 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/8/2026 | JPMorgan | Priyanka Grover | New Coverage | Overweight (N/A) |
60.00 (N/A) |
25.45 (23.25) |
-8.64% | Details |
| 6/3/2026 | Rodman & Renshaw | Seema Sheoran | New Coverage | Buy (N/A) |
70.00 (N/A) |
26.14 (23.25) |
-11.06% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
